Comparative Genomics and Proteomics in Drug Discovery

Vol 58

Edited by John Parrington, Kevin Coward

© 2006 – Taylor & Francis

164 pages | 27 B/W Illus.

Purchasing Options:
Hardback: 9780415396530
pub: 2006-11-08
US Dollars$274.00
x

About the Book

Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.

Table of Contents

1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The Practical Implications of Comparative Kinetoplastid Genomics 3. The Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach 6. 'Omics' in Translational Medicine : Are They Lost in Translation? 7. Drug-Target Discovery In Silico : Using the Web to Identify Novel Molecular Targets for Drug Action

About the Editors

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

About the Series

Society for Experimental Biology

Learn more…

Subject Categories

BISAC Subject Codes/Headings:
SCI000000
SCIENCE / General
SCI008000
SCIENCE / Life Sciences / Biology / General
SCI029000
SCIENCE / Life Sciences / Genetics & Genomics
SCI049000
SCIENCE / Life Sciences / Biology / Molecular Biology